Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 18;130(4):496-511.
doi: 10.1161/CIRCRESAHA.121.320702. Epub 2022 Feb 17.

Sex Differences in Peripheral Artery Disease

Affiliations
Review

Sex Differences in Peripheral Artery Disease

Maria Pabon et al. Circ Res. .

Abstract

Peripheral artery disease (PAD) is a prevalent condition that confers substantial morbidity and mortality and remains underdiagnosed as well as undertreated in the overall population. Although PAD prevalence is similar or higher in women compared with men, associations of traditional and nontraditional risk factors with PAD and clinical manifestations of PAD differ by sex and may contribute to delayed or lack of diagnosis in women. Such sex-based differences in the manifestation of PAD may arise from sexual dimorphism in the vascular substrate in health as well as sex variation in the responses to vascular stressors. Despite the availability of proven therapies for improving symptoms and reducing risk of ischemic cardiovascular and limb events among patients with diagnosed PAD, important sex differences in treatment and outcomes have been observed. We provide an overview of current knowledge regarding sex differences in the epidemiology, pathophysiology, clinical presentation, and management of PAD.

Keywords: adult; cardiovascular disease; incidence; prevalence; risk factor.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Sex Differences in Responses to Vascular Stressors and Sequelae.
A conventional paradigm proposes that when the same arterial structural and functional substrate is exposed to stressors, sex differences in response to these stressors lead to variations in manifest peripheral vascular disease including the predominance of aortic aneurysm and dissection in men as well as the likely higher prevalence of classic atherosclerotic lower extremity disease in women that also tends to present more as multivessel disease in women compared to men. Emerging evidence suggests that intrinsic sex differences in the arterial substrate, arising from genetic or epigenetic factors, likely also contribute to sexual dimorphism in vascular disease phenotypes.
Figure 2.
Figure 2.. Sex-Agnostic and Sex-Specific Risk Factors for Peripheral Arterial Disease.
A number of sex-agnostic risk factors for peripheral arterial disease have been identified, with smoking being among the most prominent and potentially contributing a more substantial burden of disease risk in women compared to men, based on analyses of tobacco metabolite associations. The excess burden and multivessel predominance of peripheral arterial disease in women may also arise from a sex-specific predisposition for endothelial dysfunction and, in turn, arterial dysfunction and disease in the setting of age-related estrogen deficiency occurring either with or without a preceding vascular disorder of pregnancy event.

References

    1. Leeper NJ and Hamburg NM. Peripheral Vascular Disease in 2021. Circulation Research. 2021;128:1803–1804. - PMC - PubMed
    1. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fernández-Solà J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, Kassebaum N, Koroshetz W, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de Oliveira G, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, Stark B, Sundström J, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V and Group G-N-JGBoCDW. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76:2982–3021. - PMC - PubMed
    1. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Lee AJ, Price JF, d’Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodríguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CD, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus JA, Ogren M, Hedblad B, Witteman JC, Breteler MM, Hunink MG, Hofman A, Criqui MH, Langer RD, Fronek A, Hiatt WR, Hamman R, Resnick HE, Guralnik J and Collaboration ABI. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300:197–208. - PMC - PubMed
    1. Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, Darius H, Burghaus I, Trampisch HJ and Group GEToABIS. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation. 2009;120:2053–61. - PubMed
    1. Colantonio LD, Hubbard D, Monda KL, Mues KE, Huang L, Dai Y, Jackson EA, Brown TM, Rosenson RS, Woodward M, Muntner P and Farkouh ME. Atherosclerotic Risk and Statin Use Among Patients With Peripheral Artery Disease. J Am Coll Cardiol. 2020;76:251–264. - PubMed

Publication types

MeSH terms

Substances